Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Within-subject interlaboratory variability of QuantiFERON-TB gold in-tube tests.

Whitworth WC, Hamilton LR, Goodwin DJ, Barrera C, West KB, Racster L, Daniels LJ, Chuke SO, Campbell BH, Bohanon J, Jaffar AT, Drane W, Maserang D, Mazurek GH.

PLoS One. 2012;7(9):e43790. doi: 10.1371/journal.pone.0043790. Epub 2012 Sep 6.

2.

Variability of the QuantiFERON®-TB gold in-tube test using automated and manual methods.

Whitworth WC, Goodwin DJ, Racster L, West KB, Chuke SO, Daniels LJ, Campbell BH, Bohanon J, Jaffar AT, Drane W, Sjoberg PA, Mazurek GH.

PLoS One. 2014 Jan 23;9(1):e86721. doi: 10.1371/journal.pone.0086721. eCollection 2014.

3.

Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays.

Mazurek GH, Zajdowicz MJ, Hankinson AL, Costigan DJ, Toney SR, Rothel JS, Daniels LJ, Pascual FB, Shang N, Keep LW, LoBue PA.

Clin Infect Dis. 2007 Oct 1;45(7):826-36. Epub 2007 Aug 24.

PMID:
17806046
4.

Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts.

Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF, Cobelens FG, van Houte AJ, Bossink AW.

Am J Respir Crit Care Med. 2007 Mar 15;175(6):618-27. Epub 2006 Dec 14.

PMID:
17170386
5.

Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing.

van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, Badri M, Zumla A, Sechi LA, Bateman ED, Dheda K.

Am J Respir Crit Care Med. 2009 Jul 1;180(1):49-58. doi: 10.1164/rccm.200811-1704OC. Epub 2009 Apr 2.

PMID:
19342414
6.

Unusual interferon gamma measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube tests.

Powell RD 3rd, Whitworth WC, Bernardo J, Moonan PK, Mazurek GH.

PLoS One. 2011;6(6):e20061. doi: 10.1371/journal.pone.0020061. Epub 2011 Jun 8.

7.

[Evolution of IGRA researches].

Ariga H, Harada N.

Kekkaku. 2008 Sep;83(9):641-52. Review. Japanese.

PMID:
18979999
8.

Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers.

Ringshausen FC, Nienhaus A, Schablon A, Schlösser S, Schultze-Werninghaus G, Rohde G.

BMC Infect Dis. 2010 Jul 23;10:220. doi: 10.1186/1471-2334-10-220.

9.

QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy.

Saracino A, Scotto G, Fornabaio C, Martinelli D, Faleo G, Cibelli D, Tartaglia A, Di Tullio R, Fazio V, Prato R, Monno L, Angarano G.

New Microbiol. 2009 Oct;32(4):369-76.

10.

[The clinical application of quantiferon TB-2G: its usefulness and limitations].

Sato S, Nagai H.

Kekkaku. 2011 Feb;86(2):101-12. Japanese.

PMID:
21404654
11.

[The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].

Matsumoto T, Yamazaki T.

Kekkaku. 2014 Sep;89(9):743-55. Japanese.

PMID:
25730946
12.
13.

Agreement between QuantiFERON®-TB Gold In-Tube and the tuberculin skin test and predictors of positive test results in Warao Amerindian pediatric tuberculosis contacts.

Verhagen LM, Maes M, Villalba JA, d'Alessandro A, Rodriguez LP, España MF, Hermans PW, de Waard JH.

BMC Infect Dis. 2014 Jul 11;14:383. doi: 10.1186/1471-2334-14-383.

14.

Comparison of interferon gamma-inducible protein-10 and interferon gamma-based QuantiFERON TB Gold assays with tuberculin skin test in HIV-infected subjects.

Kabeer BS, Sikhamani R, Raja A.

Diagn Microbiol Infect Dis. 2011 Nov;71(3):236-43. doi: 10.1016/j.diagmicrobio.2011.07.012.

15.

Screening for tuberculosis infection in spanish healthcare workers: Comparison of the QuantiFERON-TB gold in-tube test with the tuberculin skin test.

Alvarez-León EE, Espinosa-Vega E, Santana-Rodríguez E, Molina-Cabrillana JM, Pérez-Arellano JL, Caminero JA, Serrano-Aguilar P.

Infect Control Hosp Epidemiol. 2009 Sep;30(9):876-83. doi: 10.1086/598519.

PMID:
19614541
16.

Comparison of tuberculin skin test and QuantiFERON®-TB Gold In-Tube for the diagnosis of childhood tuberculosis.

Uzunhan O, Törün SH, Somer A, Salman N, Köksalan K.

Pediatr Int. 2015 Oct;57(5):893-6. doi: 10.1111/ped.12659. Epub 2015 Aug 26.

PMID:
25903010
17.

New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.

Butera O, Chiacchio T, Carrara S, Casetti R, Vanini V, Meraviglia S, Guggino G, Dieli F, Vecchi M, Lauria FN, Marruchella A, Laurenti P, Singh M, Caccamo N, Girardi E, Goletti D.

BMC Infect Dis. 2009 Nov 21;9:182. doi: 10.1186/1471-2334-9-182.

18.

Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.

Dyrhol-Riise AM, Gran G, Wentzel-Larsen T, Blomberg B, Haanshuus CG, Mørkve O.

BMC Infect Dis. 2010 Mar 8;10:57. doi: 10.1186/1471-2334-10-57.

19.

The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.

Chen YM, Chen HH, Lai KL, Hung WT, Lan JL, Chen DY.

Rheumatology (Oxford). 2013 Apr;52(4):697-704. doi: 10.1093/rheumatology/kes365. Epub 2012 Dec 22.

PMID:
23264552
20.

[Effects of prophylaxis on QuantiFERON TB-2G responses among children].

Higuchi K, Okada K, Harada N, Mori T.

Kekkaku. 2008 Sep;83(9):603-9. Japanese.

PMID:
18979994

Supplemental Content

Support Center